Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.

Feldstein AE, Alkhouri N, De Vito R, Alisi A, Lopez R, Nobili V.

Am J Gastroenterol. 2013 Sep;108(9):1526-31. doi: 10.1038/ajg.2013.168.

PMID:
23752877
2.

Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.

Chan WK, Sthaneshwar P, Nik Mustapha NR, Mahadeva S.

PLoS One. 2014 Sep 3;9(9):e105903. doi: 10.1371/journal.pone.0105903.

3.

Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.

Shen J, Chan HL, Wong GL, Chan AW, Choi PC, Chan HY, Chim AM, Yeung DK, Yu J, Chu WC, Wong VW.

Aliment Pharmacol Ther. 2012 Dec;36(11-12):1057-66. doi: 10.1111/apt.12091.

4.

Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.

Aida Y, Abe H, Tomita Y, Nagano T, Seki N, Sugita T, Itagaki M, Ishiguro H, Sutoh S, Aizawa Y.

Int J Clin Exp Med. 2014 Nov 15;7(11):4191-8.

5.

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.

Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE.

Hepatology. 2006 Jul;44(1):27-33.

PMID:
16799979
6.

Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.

Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Yerci O, Oral AY, Gul CB, Gurel S, Nak SG, Gulten M.

Med Sci Monit. 2009 Apr;15(4):CR189-93.

PMID:
19333204
7.

Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.

Tsutsui M, Tanaka N, Kawakubo M, Sheena Y, Horiuchi A, Komatsu M, Nagaya T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Tanaka E, Sano K.

J Clin Gastroenterol. 2010 Jul;44(6):440-7. doi: 10.1097/MCG.0b013e3181bdefe2.

PMID:
20104187
8.

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A.

Obes Surg. 2008 Nov;18(11):1430-7. doi: 10.1007/s11695-008-9506-y.

PMID:
18500507
9.

Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers.

Shen J, Chan HL, Wong GL, Choi PC, Chan AW, Chan HY, Chim AM, Yeung DK, Chan FK, Woo J, Yu J, Chu WC, Wong VW.

J Hepatol. 2012 Jun;56(6):1363-70. doi: 10.1016/j.jhep.2011.12.025.

PMID:
22314419
10.

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.

Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ.

Hepatology. 2009 Oct;50(4):1072-8. doi: 10.1002/hep.23050.

11.

Plasma Cytokeratin-18 Level As a Novel Biomarker for Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease.

Mandelia C, Collyer E, Mansoor S, Lopez R, Lappe S, Nobili V, Alkhouri N.

J Pediatr Gastroenterol Nutr. 2016 Aug;63(2):181-7. doi: 10.1097/MPG.0000000000001136.

PMID:
26835904
12.

Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH.

Pimentel CF, Jiang ZG, Otsubo T, Feldbrügge L, Challies TL, Nasser I, Robson S, Afdhal N, Lai M.

Dig Dis Sci. 2016 Mar;61(3):905-12. doi: 10.1007/s10620-015-3916-1.

PMID:
26462489
13.

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease.

Kim YS, Jung ES, Hur W, Bae SH, Choi JY, Song MJ, Kim CW, Jo SH, Lee CD, Lee YS, Choi SW, Yang JM, Jang JW, Kim SG, Jung SW, Kim HK, Chae HB, Yoon SK.

Clin Mol Hepatol. 2013 Jun;19(2):120-30. doi: 10.3350/cmh.2013.19.2.120.

14.

Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.

Polyzos SA, Kountouras J, Papatheodorou A, Katsiki E, Patsiaoura K, Zafeiriadou E, Papadopoulou E, Zavos C, Terpos E.

Ann Hepatol. 2013 Sep-Oct;12(5):749-57.

15.

Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD.

Fitzpatrick E, Mitry RR, Quaglia A, Hussain MJ, DeBruyne R, Dhawan A.

J Pediatr Gastroenterol Nutr. 2010 Oct;51(4):500-6. doi: 10.1097/MPG.0b013e3181e376be.

PMID:
20808246
16.

Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease.

Cusi K, Chang Z, Harrison S, Lomonaco R, Bril F, Orsak B, Ortiz-Lopez C, Hecht J, Feldstein AE, Webb A, Louden C, Goros M, Tio F.

J Hepatol. 2014 Jan;60(1):167-74. doi: 10.1016/j.jhep.2013.07.042.

PMID:
23973932
17.

The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.

Malik R, Chang M, Bhaskar K, Nasser I, Curry M, Schuppan D, Byrnes V, Afdhal N.

J Gastroenterol Hepatol. 2009 Apr;24(4):564-8.

PMID:
19378390
18.

Plasma cathepsin D levels: a novel tool to predict pediatric hepatic inflammation.

Walenbergh SM, Houben T, Hendrikx T, Jeurissen ML, van Gorp PJ, Vreugdenhil AC, Adriaanse MP, Buurman WA, Hofker MH, Mosca A, Lindsey PJ, Alisi A, Liccardo D, Panera N, Koek GH, Nobili V, Shiri-Sverdlov R.

Am J Gastroenterol. 2015 Mar;110(3):462-70. doi: 10.1038/ajg.2015.29.

PMID:
25732418
19.

Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.

Pirvulescu I, Gheorghe L, Csiki I, Becheanu G, Dumbravă M, Fica S, Martin S, Sarbu A, Gheorghe C, Diculescu M, Copăescu C.

Chirurgia (Bucur). 2012 Nov-Dec;107(6):772-9.

20.

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.

Diab DL, Yerian L, Schauer P, Kashyap SR, Lopez R, Hazen SL, Feldstein AE.

Clin Gastroenterol Hepatol. 2008 Nov;6(11):1249-54. doi: 10.1016/j.cgh.2008.07.016.

Items per page

Supplemental Content

Support Center